How SARS-CoV-2 replicates once it enters the cells, has made surprising discoveries that could be the foundation for future antiviral therapies. It also has important implications as replication of the SARS-CoV-2 has, so far, received less attention from researchers. 1/
The viral life cycle can be broken down into 2 main stages: the 1st where the virus enters the cell, & 2nd is replication where the virus uses the molecular machinery of the cell to replicate itself by building its parts, assembling them into new viruses that can then exit 2/
The new study focuses on how the Envelope protein of SARS-CoV-2 controls late stages of viral replication. Coronaviral Envelope (E) proteins are pentameric viroporins that play essential roles in assembly, release, and pathogenesis. 3/
The researchers marked the Envelope protein with fluorescent tags to track its movement within cells and used proteomics to identify key pathways that allow SARS-CoV-2 to take over the internal compartments of the infected cell—known as organelles—for its replication. 4/
They identified a surprising aspect of its replication in its use of a compartment called the lysosome during viral release. The Envelope protein localises itself to the Golgi complex and to lysosomes. 5/
Lysosomes are acidic, degradative organelles, but SARS-CoV-2 uses its Envelope protein as an ion-channel to neutralize their acidity and so enhance viral release. 6/
So the data outline trafficking pathways and routes taken by the E viroporin of SARS-CoV-2, linking viral sequences with cellular factors that govern movement between the ER, Golgi, and lysosomes. 7/
Such insights on replication could eventually be applied to create new antivirals that inhibit the channel activity of the Envelope protein. These could apply not only to SARS-CoV-2, but to the β-coronavirus family and any other virus that replicates with the same mechanisms. 8/
These findings show what an exquisite cell biologist the SARS-CoV-2 virus is, and shed new light onto how infection with SARS-CoV-2 can disrupt the function of essential intracellular compartments, known as organelles 9/9
A new study confirms a strong association between #LongCOVID and cognitive impairment
The study found that the prevalence of longCOVID was 7.4% and cognitive impairment was 13.4% with both rates higher among women, aged 18-64 years. 1/
Researchers also find vaccine effectiveness of 3 or more doses of mRNA Covid vaccine vs <3 was 38% for longCOVID and 35% for cognitive impairment (CI). For CI, apparent vaccine effectiveness was similar for respondents with or without longCOVID 2/
However, many questions unanswered -HOW the vaccines work & if they can slow progression to Alzheimer Disease (AD)?
It is possible that a precursor protein associated with AD might be similar enough to Spike protein targeted by the vaccines to stimulate an immune response 3/
Protein in embryo cells might help decide!
A new study finds that gene that codes for structural protein could determine the dominant side of the human brain. 1/
During the embryonic stage of human development, the left & right brain hemispheres get wired differently, which determines innate behaviours, such as where we lean when we hug someone, on which side of our mouth we tend to chew our food & which hand is our dominant one. 2/
This turns out to be the left hand for around 10% of the human population. Because most people have a clear preference for one hand over the other, finding genes linked to handedness can provide clues for the genetic basis of the brain’s left–right asymmetry. 3/
A new study identified differential pathogenesis of SARS-CoV-2 infection in children versus adults. This is reflected by finding a significant number of genes that were differentially expressed in lung cells derived from children as compared to adults. 1/
The ability of SARS-CoV-2 to evade antiviral immune signaling in the airway contributes to the severity of COVID-19 disease.
Additionally, COVID-19 is influenced by age and has more severe presentations in older individuals. 2/
This raises questions about innate immune signaling as a function of lung development and age.
A new study investigated the transcriptome of different cell populations of the airway epithelium using pediatric and adult lung tissue samples 3/
Mutations in the spike protein of SARS-CoV-2 can lead to successful escape from protective antibodies, and hence antigenic drift. 1/
Most of these spike mutations are known to occur in the RBD & N-terminal domain. In contrast, while human antibodies also target the conserved S2 domain, whether S2 mutations also contribute to SARS-CoV-2 antigenic drift remains largely elusive. 2/
A new study used a deep mutational scanning experiment to identify S2 mutations that weaken binding to a multidonor class of S2 antibodies. 3/
There is a coevolutionary race between the human immune system & SARS-CoV-2, mirroring the ‘Red Queen hypothesis’ of evolutionary biology. The immune system generates neutralizing antibodies targeting the SARS2 spike’s RBD while virus evolves to evade antibody recognition. 1/
A new study establishes a synthetic coevolution system combining high-throughput screening of antibody and RBD variant libraries with protein mutagenesis, surface display, and deep sequencing. 2/
The researchers deployed eSHM for antibody library generation and mammalian surface display screening to identify antibody clonotypes that bind to different RBD variants. 3/
Why SARS-CoV-2 elicits mild symptoms at first but then, for a subset of patients, turn potentially fatal a week or so after infection? A recent study showed that distinct stages of illness correspond with the coronavirus acting differently in 2 different populations of cells 1/
The study’s findings may provide a roadmap for addressing cytokine storms and other excessive immune reactions that drive serious COVID-19. 2/
The team found that when SARS-2 infects its first-phase targets, cells in the lining of lung, two viral proteins circulate within those cells—one that works to activate the immune system & a 2nd that, paradoxically, blocks that signal, resulting in little or no inflammation 3/